| Synonyms: | |
| Status: | Phase 1 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | I3733P75ML |
| InChI Key | FIMYFEGKMOCQKT-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C20H19F3IN3O5 |
| Molecular Weight | 565.29 |
| AlogP | 3.16 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 8.0 |
| Polar Surface Area | 100.13 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 32.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Dual specificity mitogen-activated protein kinase kinase 1 inhibitor |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Kinase
Protein Kinase
CMGC protein kinase group
CMGC protein kinase MAPK family
CMGC protein kinase ERK subfamily
|
- | 5.8 | - | - | - | |
|
Enzyme
Kinase
Protein Kinase
STE protein kinase group
STE protein kinase STE7 family
|
- | 8.8 | 0.24-19 | - | - | |
|
Enzyme
Transferase
|
- | - | - | - | 20.36 | |
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIb
|
- | - | - | - | -62.55-4 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL1614766 |
| DrugBank | DB12933 |
| FDA SRS | I3733P75ML |
| Guide to Pharmacology | 9910 |
| PDB | 3OR |
| PubChem | 11548630 |
| SureChEMBL | SCHEMBL1562083 |
| ZINC | ZINC000043103796 |